Andrew D. Ashe, See Remarks at Verve Therapeutics, Inc. (VERV), bought 4,000 shares at $32.10 ($128K) on 2021-12-02, disclosed to the SEC on 2021-12-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| DYAX | SELL | 2015-08-05 | $1.5M | — | Filing → |
| DYAX | SELL | 2015-03-06 | $37K | — | Filing → |
| DYAX | SELL | 2015-02-26 | $23K | — | Filing → |